Buprenorphine and Naloxone
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50742-397 -
Package NDC
50742-397-30 -
Application number
ANDA212756 -
SPL ID
4db0df39-ce1f-bb08-e063-6294a90a3a4a -
SPL set ID
4951ec29-609b-4836-b0e4-0d9c1d6ae6fe -
UNII
F850569PQR -
UNII
56W8MW3EN1 -
RxCUI
1010600 -
RxCUI
1010604 -
RxCUI
1307056 -
RxCUI
1307061
What the source publishes
- Labeler
- INGENUS PHARMACEUTICALS, LLC
- Active ingredients
- buprenorphine and naloxone
- Form
- FILM
- Routes
- BUCCAL, SUBLINGUAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Buprenorphine and Naloxone",
"splId": "4db0df39-ce1f-bb08-e063-6294a90a3a4a",
"labels": [
{
"setId": "4951ec29-609b-4836-b0e4-0d9c1d6ae6fe",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4951ec29-609b-4836-b0e4-0d9c1d6ae6fe",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4951ec29-609b-4836-b0e4-0d9c1d6ae6fe"
}
],
"routes": [
"BUCCAL",
"SUBLINGUAL"
],
"labeler": "INGENUS PHARMACEUTICALS, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 POUCH in 1 CARTON (50742-397-30) / 1 FILM in 1 POUCH (50742-397-01)",
"package_ndc": "50742-397-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20240808"
}
],
"productId": "50742-397_4db0df39-ce1f-bb08-e063-6294a90a3a4a",
"useDomain": "unknown",
"dosageForm": "FILM",
"productNdc": "50742-397",
"deaSchedule": "CIII",
"genericName": "buprenorphine and naloxone",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BUPRENORPHINE HYDROCHLORIDE",
"strength": "2 mg/1"
},
{
"name": "NALOXONE HYDROCHLORIDE",
"strength": ".5 mg/1"
}
],
"applicationNumber": "ANDA212756",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230829",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"F850569PQR",
"56W8MW3EN1"
],
"rxcui": [
"1010600",
"1010604",
"1307056",
"1307061"
],
"spl_set_id": [
"4951ec29-609b-4836-b0e4-0d9c1d6ae6fe"
],
"manufacturer_name": [
"INGENUS PHARMACEUTICALS, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50742-397_4db0df39-ce1f-bb08-e063-6294a90a3a4a"